These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Gerson MC; Caldwell JH; Ananthasubramaniam K; Clements IP; Henzlova MJ; Amanullah A; Jacobson AF Circ Cardiovasc Imaging; 2011 Mar; 4(2):87-93. PubMed ID: 21193691 [TBL] [Abstract][Full Text] [Related]
3. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy. Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722 [TBL] [Abstract][Full Text] [Related]
4. [Scintigraphic assessment of blood flow regulation and sympathetic function of the diabetic heart]. Schnell O Dtsch Med Wochenschr; 2002 May; 127(18):965-70. PubMed ID: 11987017 [No Abstract] [Full Text] [Related]
5. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure. Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914 [TBL] [Abstract][Full Text] [Related]
6. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574 [TBL] [Abstract][Full Text] [Related]
7. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. Schnell O; Muhr D; Weiss M; Kirsch CM; Haslbeck M; Tatsch K; Standl E J Diabetes Complications; 1997; 11(5):307-13. PubMed ID: 9334913 [TBL] [Abstract][Full Text] [Related]
8. Sympathetic dysinnervation, QT variability and the limitations of statistical work-up. Rosenheck S J Cardiovasc Electrophysiol; 2013 Mar; 24(3):314-5. PubMed ID: 23217167 [No Abstract] [Full Text] [Related]
9. [Evaluation of cardiac sympathetic innervation with 123I-metaiodobenzylguanidine in patients with diabetes mellitus]. Lumbreras Vega L; Fernández Soto M; Nevado Jiménez A; Becerra García D; Nieto Serrano R; Fernández Fernández B; Escobar Jiménez F; Martínez Sampere JJ Rev Esp Cardiol; 1998; 51 Suppl 1():60-6. PubMed ID: 9549400 [TBL] [Abstract][Full Text] [Related]
10. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. Langer A; Freeman MR; Josse RG; Armstrong PW J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904 [TBL] [Abstract][Full Text] [Related]
11. Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic control. Muhr-Becker D; Weiss M; Tatsch K; Wolfram G; Standl E; Schnell O Exp Clin Endocrinol Diabetes; 1999; 107(5):306-12. PubMed ID: 10482043 [TBL] [Abstract][Full Text] [Related]
13. Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up. Schnell O; Muhr D; Dresel S; Weiss M; Haslbeck M; Standl E Diabet Med; 1997 Jan; 14(1):57-62. PubMed ID: 9017355 [TBL] [Abstract][Full Text] [Related]
14. Heart rate complexity and cardiac sympathetic dysinnervation in patients with type 2 diabetes mellitus. Baumert M; Sacre JW Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5570-3. PubMed ID: 24110999 [TBL] [Abstract][Full Text] [Related]
15. Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy. Schnell O; Hammer K; Muhr-Becker D; Ziegler A; Weiss M; Tatsch K; Standl E J Diabetes Complications; 2002; 16(3):220-7. PubMed ID: 12015192 [TBL] [Abstract][Full Text] [Related]
16. The clinical value of cardiac sympathetic imaging in heart failure. Christensen TE; Kjaer A; Hasbak P Clin Physiol Funct Imaging; 2014 May; 34(3):178-82. PubMed ID: 24138454 [TBL] [Abstract][Full Text] [Related]
17. Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Paolillo S; Rengo G; Pagano G; Pellegrino T; Savarese G; Femminella GD; Tuccillo M; Boemio A; Attena E; Formisano R; Petraglia L; Scopacasa F; Galasso G; Leosco D; Trimarco B; Cuocolo A; Perrone-Filardi P Diabetes Care; 2013 Aug; 36(8):2395-401. PubMed ID: 23530014 [TBL] [Abstract][Full Text] [Related]
18. Does cardiac sympathetic innervation imaging fulfill an unmet need for managing atrial fibrillation? Crawford MH JACC Cardiovasc Imaging; 2011 Jan; 4(1):87-8. PubMed ID: 21232709 [No Abstract] [Full Text] [Related]
19. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. Sacre JW; Franjic B; Jellis CL; Jenkins C; Coombes JS; Marwick TH JACC Cardiovasc Imaging; 2010 Dec; 3(12):1207-15. PubMed ID: 21163448 [TBL] [Abstract][Full Text] [Related]
20. Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. Perrone-Filardi P; Paolillo S; Dellegrottaglie S; Gargiulo P; Savarese G; Marciano C; Casaretti L; Cecere M; Musella F; Pirozzi E; Parente A; Cuocolo A Heart; 2011 Nov; 97(22):1828-33. PubMed ID: 21917663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]